Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Egypt's Sisi receives coronavirus vaccine

Published 2021-04-25, 10:04 a/m
© Reuters. Egyptian President Abdel Fattah al-Sisi receives a dose of a vaccine against the coronavirus disease (COVID-19) in Cairo

CAIRO (Reuters) - Egyptian President Abdel Fattah al-Sisi has received a coronavirus vaccination under a nationwide vaccination drive, his office said on Sunday.

The statement from the presidency did not give details on the type of vaccine Sisi received.

Egypt has started administering doses of AstraZeneca (NASDAQ:AZN)'s COVID-19 vaccine under the global COVAX agreement to provide vaccines for lower-income countries, as well as jabs produced by China's Sinopharm.

Awad Tag el-Din, Sisi's adviser for health affairs, told a local news channel on Friday that around half a million people in Egypt had been vaccinated so far.

The number of coronavirus cases has been steadily rising in recent weeks and the health ministry reported 912 new cases and 39 more deaths as of Saturday.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.